April 17, 2017 Technical variability in NGS immune gene expression and mutation profiling has a nominal effect on tumor classification Read more »
April 1, 2017 NGS reveals specimen characteristics have minimal impact on immune gene expression signature Read more »
April 1, 2017 Analytical validation of an immune response assay for classifying solid tumors Read more »
October 21, 2016 Robust detection of immune transcripts in FFPE samples using targeted RNA sequencing Read more »
February 1, 2018 Immune deserts: Low CD8 gene expression correlates with non-response to checkpoint inhibition Read more »
November 2, 2018 Tumor mutational burden (TMB) ring study: Comparison of multiple targeted next-generation sequencing (NGS) platforms Read more »
February 1, 2019 Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients Read more »
January 19, 2019 Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing Read more »
November 1, 2018 Development of a next-generation sequencing-based microsatellite instability assay (MSI NGS) for solid tumor testing Read more »